Pemetrexed-based first-line chemotherapy had particularly prominent objective response rate for advanced NSCLC: A network meta-analysis

Lv Yuankai; Cao Zhuo; Pan Jiongwei; Gong Enhui; Zheng Hao; Cai Xiaoping

doi:10.1515/med-2021-0202

Open Medicine (Jan 2021)

Pemetrexed-based first-line chemotherapy had particularly prominent objective response rate for advanced NSCLC: A network meta-analysis

Lv Yuankai,
Cao Zhuo,
Pan Jiongwei,
Gong Enhui,
Zheng Hao,
Cai Xiaoping

Affiliations

Lv Yuankai: Department of Respiratory, Lishui People’s Hospital, No.15 Dazhong Road, Liandu District, Lishui, Zhejiang, 323000, People’s Republic of China
Cao Zhuo: Department of Respiratory, Lishui People’s Hospital, No.15 Dazhong Road, Liandu District, Lishui, Zhejiang, 323000, People’s Republic of China
Pan Jiongwei: Department of Respiratory, Lishui People’s Hospital, No.15 Dazhong Road, Liandu District, Lishui, Zhejiang, 323000, People’s Republic of China
Gong Enhui: Department of Respiratory, Lishui People’s Hospital, No.15 Dazhong Road, Liandu District, Lishui, Zhejiang, 323000, People’s Republic of China
Zheng Hao: Department of Respiratory, Lishui People’s Hospital, No.15 Dazhong Road, Liandu District, Lishui, Zhejiang, 323000, People’s Republic of China
Cai Xiaoping: Department of Respiratory, Lishui People’s Hospital, No.15 Dazhong Road, Liandu District, Lishui, Zhejiang, 323000, People’s Republic of China

DOI: https://doi.org/10.1515/med-2021-0202
Journal volume & issue: Vol. 16, no. 1
pp. 183 – 191

Abstract

Read online

The aim of the present work was to investigate the clinical efficacy of first-line chemotherapy regimens in the treatment of advanced non-small cell lung cancer (NSCLC) through a comprehensive network meta-analysis (NMA).

Published in Open Medicine

ISSN: 2391-5463 (Online)
Publisher: De Gruyter
Country of publisher: Poland
LCC subjects: Medicine
Website: https://www.degruyter.com/journal/key/med/html

About the journal

Abstract

Keywords